Pembrolizumab: FDA adverse event reports
105,146 FDA FAERS reports mention Pembrolizumab. 92,007 reports have a serious outcome flag.
Reported reactions
- Malignant Neoplasm Progression: 12,018 reports
- Death: 5,868 reports
- Diarrhoea: 5,750 reports
- Fatigue: 5,146 reports
- Off Label Use: 4,760 reports
- Pyrexia: 3,892 reports
- Rash: 3,730 reports
- Nausea: 3,599 reports
- Product Use In Unapproved Indication: 3,541 reports
- Decreased Appetite: 3,320 reports
- Hypertension: 3,235 reports
- Hypothyroidism: 2,922 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.